The Shading Sign: Is It Exclusive of Endometriomas?

Detalhes bibliográficos
Autor(a) principal: Lopes Dias, J
Data de Publicação: 2015
Outros Autores: Veloso Gomes, F, Lucas, R, Cunha, TM
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/2326
Resumo: OBJECTIVES: To investigate if the shading sign is an exclusive MRI feature of endometriomas or endometrioid tumors, and to analyze its different patterns. METHODS: Three hundred and fourty six women with adnexal masses who underwent 1.5/3-T MRI were included in this retrospective, board-approved study. The shading sign was found in 56 patients, but five cases were excluded due to lack of imaging follow-up or histological correlation. The final sample included 51 women. The type of tumor and the pattern of shading were recorded for each case. RESULTS: Thirty endometriomas and five endometrioid carcinomas were found. The remaining 16 cases corresponded to other benign and malignant tumors. The overall sensitivity, specificity, positive predictive value, and negative predictive value were 73%, 93%, 59%, and 96%, respectively. Restricting the analysis to cystic lesions without solid or fat component, sensitivity, specificity, positive predictive value, and negative predictive value were 73%, 96%, 94%, and 80%. Five shading patterns were identified: layering (15.7%), liquid-liquid level (11.8%), homogenous (45.1%), heterogeneous (11.8%), and focal/multifocal shading within a complex mass (19.6%). No significant correlation was found between these patterns and the type of tumor. CONCLUSIONS: The shading sign is not exclusive of endometriomas or endometrioid tumors. Homogenous shading was the most prevalent pattern in endometriomas and half of the cases with focal/multifocal shading within a complex mass were endometrioid carcinomas.
id RCAP_1f898ef704d773c40bbe3a9a4f63c7ab
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/2326
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The Shading Sign: Is It Exclusive of Endometriomas?HSJ IMAHSAC IMACarcinoma, Endometrioid/pathologyDiagnosis, DifferentialEndometrial Neoplasms/pathologyEndometriosis/pathologyEndometrium/pathologyMagnetic Resonance ImagingReproducibility of ResultsRetrospective StudiesSensitivity and SpecificityOBJECTIVES: To investigate if the shading sign is an exclusive MRI feature of endometriomas or endometrioid tumors, and to analyze its different patterns. METHODS: Three hundred and fourty six women with adnexal masses who underwent 1.5/3-T MRI were included in this retrospective, board-approved study. The shading sign was found in 56 patients, but five cases were excluded due to lack of imaging follow-up or histological correlation. The final sample included 51 women. The type of tumor and the pattern of shading were recorded for each case. RESULTS: Thirty endometriomas and five endometrioid carcinomas were found. The remaining 16 cases corresponded to other benign and malignant tumors. The overall sensitivity, specificity, positive predictive value, and negative predictive value were 73%, 93%, 59%, and 96%, respectively. Restricting the analysis to cystic lesions without solid or fat component, sensitivity, specificity, positive predictive value, and negative predictive value were 73%, 96%, 94%, and 80%. Five shading patterns were identified: layering (15.7%), liquid-liquid level (11.8%), homogenous (45.1%), heterogeneous (11.8%), and focal/multifocal shading within a complex mass (19.6%). No significant correlation was found between these patterns and the type of tumor. CONCLUSIONS: The shading sign is not exclusive of endometriomas or endometrioid tumors. Homogenous shading was the most prevalent pattern in endometriomas and half of the cases with focal/multifocal shading within a complex mass were endometrioid carcinomas.Springer VerlagRepositório do Centro Hospitalar Universitário de Lisboa Central, EPELopes Dias, JVeloso Gomes, FLucas, RCunha, TM2015-10-30T12:25:20Z2015-102015-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/2326engAbdom Imaging. 2015 Oct;40(7):2566-7210.1007/s00261-015-0465-1info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:36:25Zoai:repositorio.chlc.min-saude.pt:10400.17/2326Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:19:41.506392Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The Shading Sign: Is It Exclusive of Endometriomas?
title The Shading Sign: Is It Exclusive of Endometriomas?
spellingShingle The Shading Sign: Is It Exclusive of Endometriomas?
Lopes Dias, J
HSJ IMA
HSAC IMA
Carcinoma, Endometrioid/pathology
Diagnosis, Differential
Endometrial Neoplasms/pathology
Endometriosis/pathology
Endometrium/pathology
Magnetic Resonance Imaging
Reproducibility of Results
Retrospective Studies
Sensitivity and Specificity
title_short The Shading Sign: Is It Exclusive of Endometriomas?
title_full The Shading Sign: Is It Exclusive of Endometriomas?
title_fullStr The Shading Sign: Is It Exclusive of Endometriomas?
title_full_unstemmed The Shading Sign: Is It Exclusive of Endometriomas?
title_sort The Shading Sign: Is It Exclusive of Endometriomas?
author Lopes Dias, J
author_facet Lopes Dias, J
Veloso Gomes, F
Lucas, R
Cunha, TM
author_role author
author2 Veloso Gomes, F
Lucas, R
Cunha, TM
author2_role author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Lopes Dias, J
Veloso Gomes, F
Lucas, R
Cunha, TM
dc.subject.por.fl_str_mv HSJ IMA
HSAC IMA
Carcinoma, Endometrioid/pathology
Diagnosis, Differential
Endometrial Neoplasms/pathology
Endometriosis/pathology
Endometrium/pathology
Magnetic Resonance Imaging
Reproducibility of Results
Retrospective Studies
Sensitivity and Specificity
topic HSJ IMA
HSAC IMA
Carcinoma, Endometrioid/pathology
Diagnosis, Differential
Endometrial Neoplasms/pathology
Endometriosis/pathology
Endometrium/pathology
Magnetic Resonance Imaging
Reproducibility of Results
Retrospective Studies
Sensitivity and Specificity
description OBJECTIVES: To investigate if the shading sign is an exclusive MRI feature of endometriomas or endometrioid tumors, and to analyze its different patterns. METHODS: Three hundred and fourty six women with adnexal masses who underwent 1.5/3-T MRI were included in this retrospective, board-approved study. The shading sign was found in 56 patients, but five cases were excluded due to lack of imaging follow-up or histological correlation. The final sample included 51 women. The type of tumor and the pattern of shading were recorded for each case. RESULTS: Thirty endometriomas and five endometrioid carcinomas were found. The remaining 16 cases corresponded to other benign and malignant tumors. The overall sensitivity, specificity, positive predictive value, and negative predictive value were 73%, 93%, 59%, and 96%, respectively. Restricting the analysis to cystic lesions without solid or fat component, sensitivity, specificity, positive predictive value, and negative predictive value were 73%, 96%, 94%, and 80%. Five shading patterns were identified: layering (15.7%), liquid-liquid level (11.8%), homogenous (45.1%), heterogeneous (11.8%), and focal/multifocal shading within a complex mass (19.6%). No significant correlation was found between these patterns and the type of tumor. CONCLUSIONS: The shading sign is not exclusive of endometriomas or endometrioid tumors. Homogenous shading was the most prevalent pattern in endometriomas and half of the cases with focal/multifocal shading within a complex mass were endometrioid carcinomas.
publishDate 2015
dc.date.none.fl_str_mv 2015-10-30T12:25:20Z
2015-10
2015-10-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/2326
url http://hdl.handle.net/10400.17/2326
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Abdom Imaging. 2015 Oct;40(7):2566-72
10.1007/s00261-015-0465-1
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer Verlag
publisher.none.fl_str_mv Springer Verlag
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131293736239104